HUP1000366A2 - Novel proteins, their production process and use tereof - Google Patents

Novel proteins, their production process and use tereof

Info

Publication number
HUP1000366A2
HUP1000366A2 HU1000366A HUP1000366A HUP1000366A2 HU P1000366 A2 HUP1000366 A2 HU P1000366A2 HU 1000366 A HU1000366 A HU 1000366A HU P1000366 A HUP1000366 A HU P1000366A HU P1000366 A2 HUP1000366 A2 HU P1000366A2
Authority
HU
Hungary
Prior art keywords
tereof
production process
novel proteins
proteins
novel
Prior art date
Application number
HU1000366A
Other languages
Hungarian (hu)
Inventor
Peter Gal
Gabor Pal
David Heja
Peter Zavodszky
Original Assignee
Mta Enzimologiai Intezet
Eotvos Lorand Tudomanyegyetem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mta Enzimologiai Intezet, Eotvos Lorand Tudomanyegyetem filed Critical Mta Enzimologiai Intezet
Priority to HU1000366A priority Critical patent/HUP1000366A2/en
Publication of HUP1000366D0 publication Critical patent/HUP1000366D0/en
Priority to PCT/HU2011/000066 priority patent/WO2012007777A1/en
Publication of HUP1000366A2 publication Critical patent/HUP1000366A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
HU1000366A 2010-07-13 2010-07-13 Novel proteins, their production process and use tereof HUP1000366A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1000366A HUP1000366A2 (en) 2010-07-13 2010-07-13 Novel proteins, their production process and use tereof
PCT/HU2011/000066 WO2012007777A1 (en) 2010-07-13 2011-07-13 Novel proteins, process for preparation thereof, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1000366A HUP1000366A2 (en) 2010-07-13 2010-07-13 Novel proteins, their production process and use tereof

Publications (2)

Publication Number Publication Date
HUP1000366D0 HUP1000366D0 (en) 2010-10-28
HUP1000366A2 true HUP1000366A2 (en) 2012-03-28

Family

ID=45468982

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1000366A HUP1000366A2 (en) 2010-07-13 2010-07-13 Novel proteins, their production process and use tereof

Country Status (2)

Country Link
HU (1) HUP1000366A2 (en)
WO (1) WO2012007777A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103014013A (en) * 2012-11-28 2013-04-03 中国科学院海洋研究所 PtPLC (protein tyrosine phosphatase-like (proline instead of catalytic arginine), member c) gene of Pacifastin type serine protease inhibitor of portunus trituberculatus and a coding protein and application thereof
US20140363433A1 (en) 2013-03-15 2014-12-11 Omeros Corporation Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
WO2014144542A2 (en) * 2013-03-15 2014-09-18 Omeros Corporation Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same
HUP1700012A2 (en) 2017-01-06 2018-07-30 Evolveritas Kft Novel proteins and use thereof
AU2020398241A1 (en) 2019-12-04 2022-06-30 Omeros Corporation MASP-2 inhibitors and methods of use
WO2024069200A2 (en) 2022-09-29 2024-04-04 Evolveritas Biotechnológiai Korlátolt Felelősségű Társaság A modified protein scaffold and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666627B2 (en) * 2002-08-08 2010-02-23 Targetex Kft. Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof
US7919094B2 (en) * 2004-06-10 2011-04-05 Omeros Corporation Methods for treating conditions associated with MASP-2 dependent complement activation
WO2007095154A2 (en) * 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Lectin complement pathway assays and related compositions and methods

Also Published As

Publication number Publication date
HUP1000366D0 (en) 2010-10-28
WO2012007777A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
IL269322B (en) Methylphenidate-prodrugs, processes of making and using the same
IL231591A (en) Substituted benzylindazoles, process for their manufacture and uses thereof
GB201009512D0 (en) Product and process
EP2524935A4 (en) Cyclopentene-ring-opened polymer and production process thereof
EP2549623A4 (en) Rotor and process for production thereof
GB201011502D0 (en) Novel process
HU1000010D0 (en) Novel process
HU1000386D0 (en) Novel process
GB201009673D0 (en) Novel process
EP2630953A4 (en) Liposome composition and process for production thereof
GB201009676D0 (en) Novel process
EP2618139A4 (en) Biosensor and production method therefor
GB201009671D0 (en) Novel process
EP2763998A4 (en) Tri-heterocyclic derivatives, preparation process and uses thereof
SG10201602874VA (en) Protein production method
EP2694649A4 (en) Novel cutinases, their production and uses
PL2625262T3 (en) Process for protein production
EP2578725A4 (en) Covered member and process for production thereof
GB201114962D0 (en) Composition, process and product
HUP1000366D0 (en) Novel proteins, their production process and use tereof
PT2571902T (en) Novel process
PL391832A1 (en) N-trazinylammonium salts, process for their production and the use thereof
GB201122368D0 (en) Process, use and product
GB201009259D0 (en) Production process
GB201020042D0 (en) Novel process and products

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished